Cargando…

Evaluation of immunohistochemical expression of stem cell markers (NANOG and CD133) in normal, hyperplastic, and malignant endometrium

Cancer stem cells (CSC) are a potential cause for recurrence, metastasis, and resistance of tumors to different therapeutic modalities like hormonal radiotherapy and chemotherapy. We investigated two CSC markers (NANOG and CD 133) in normal, hyperplastic endometrium and endometrial carcinoma. A tota...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Kaabi, Methaq, Noel, Khalida, Al-Rubai, Abdal-jabbar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Carol Davila University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852636/ https://www.ncbi.nlm.nih.gov/pubmed/35186145 http://dx.doi.org/10.25122/jml-2021-0206

Ejemplares similares

Immunohistochemical analysis of CD44s and CD44v6 in endometriosis and adenomyosis : comparison with normal, hyperplastic, and malignant endometrium.
por: Lin, Z., et al.
Publicado: (2001)

Altered PTEN expression; a diagnostic marker for differentiating normal, hyperplastic and neoplastic endometrium
por: Sarmadi, Soheila, et al.
Publicado: (2009)

Cyclin D1 and Ki-67 expression in normal, hyperplastic and neoplastic endometrium
por: Shevra, CR, et al.
Publicado: (2015)

Mitochondrial DNA content and mass increase in progression from normal to hyperplastic to cancer endometrium
por: Cormio, Antonella, et al.
Publicado: (2012)

Immunohistochemical Expression of Retinoblastoma Gene Product in Normal, Hyperplastic and Malignant Endometrium. Correlation with p53 Protein Expression, c-erbB-2, Hormone Receptors’ Status and Proliferative Activity
por: Ioachim, E. E., et al.
Publicado: (2002)

Diagnostic Value of Cytokeratin 34 beta E12 (Ck34βE12) and α-Methylacyl-CoA racemase (AMACR) Immunohistochemical Expression in Prostatic Lesions
por: Hasan, Ikram A., et al.
Publicado: (2020)

Determining the level of stromal and epithelial cells activity in normal and hyperplastic endometrium of late reproductive and perimenopausal women
por: Chumak, Zinaida Vasilyvna, et al.
Publicado: (2023)

Alteration of the K-Ras Gene Expression in Atypical and Nonatypical Hyperplastic Endometrium
por: Izadi-Mood, Narges, et al.
Publicado: (2013)

Immunohistochemical Expression of the Stem Cell Marker CD133 in Colorectal Carcinoma
por: Suman, Sweta, et al.
Publicado: (2023)

Malignant transformation of hyperplastic gastric polyps: An immunohistochemical and pathological study of the changes of neoplastic phenotype
por: IMURA, JOHJI, et al.
Publicado: (2014)

Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas
por: Wu, Xing, et al.
Publicado: (2016)

Erratum to: Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas
por: Wu, Xing, et al.
Publicado: (2016)

Malignant Transformation and Stromal Invasion from Normal or Hyperplastic Tissues: True or False?
por: Man, Yan-gao, et al.
Publicado: (2011)

Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis
por: Hong, Injae, et al.
Publicado: (2015)

Immunohistochemical Expression Patterns of Inflammatory Cells Involved in Chronic Hyperplastic Candidosis
por: Williams, Ailish, et al.
Publicado: (2019)

Immunohistochemical Detection of Cancer Stem Cell Related Markers CD44 and CD133 in Metastatic Colorectal Cancer Patients
por: Pitule, Pavel, et al.
Publicado: (2014)

Telocytes/CD34+ Stromal Cells in the Normal, Hyperplastic, and Adenomatous Human Parathyroid Glands
por: Díaz-Flores, Lucio, et al.
Publicado: (2023)

Immunohistochemical Expression of Nanog and Its Relation with Clinicopathologic Characteristics in Breast Ductal Carcinoma
por: Saravi, Omid Emadian, et al.
Publicado: (2019)

Role of IAPs in prostate cancer progression: immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostate
por: Rodríguez-Berriguete, Gonzalo, et al.
Publicado: (2010)

Immunohistochemical Expression of CD90, CD133, and TPM1 in Relation to Gastric Cancer and H. pylori Association
por: Gamal, Noha Sayed, et al.
Publicado: (2023)

Immunohistochemical detection of CD133 is associated with tumor regression grade after chemoradiotherapy in rectal cancer
por: Hongo, Kumiko, et al.
Publicado: (2012)

Increased expression of stemness genes REX-1, OCT-4, NANOG, and SOX-2 in women with ovarian endometriosis versus normal endometrium: A case-control study
por: Shariati, Fatameh, et al.
Publicado: (2019)

CD133 Expression in Normal Skin and in Epithelial Cutaneous Tumors
por: Nam-Cha, S. H., et al.
Publicado: (2013)

A comparison of retinol binding in human hyperplastic and malignant prostate.
por: Boyd, D., et al.
Publicado: (1985)

Immunohistochemical assessment of galectin-3 during pre-implantation in mouse endometrium
por: Orazizadeh, Mahmoud, et al.
Publicado: (2013)

Immunohistochemical expression of Drosha is reduced in eutopic and ectopic endometrium of women with adenomyosis
por: Ormenezi, I., et al.
Publicado: (2022)

Comparison of 66 chemical element contents in normal and benign hyperplastic prostate
por: Zaichick, Vladimir, et al.
Publicado: (2019)

Clinicopathological and molecular analyses of hyperplastic lesions including microvesicular variant and goblet cell rich variant hyperplastic polyps and hyperplastic nodules—Hyperplastic nodule is an independent histological entity
por: Uesugi, Noriyuki, et al.
Publicado: (2021)

MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
por: Melguizo, Consolación, et al.
Publicado: (2012)

CD73 expression in normal, hyperplastic, and neoplastic thyroid: a systematic evaluation revealing CD73 overexpression as a feature of papillary carcinomas
por: Monteiro, Inês, et al.
Publicado: (2021)

Clinicopathological and immunohistochemical characterization of papillary proliferation of the endometrium: A single institutional experience
por: Park, Cheol Keun, et al.
Publicado: (2016)

Immunohistochemical analysis of SOX2 expression in small-cell neuroendocrine carcinoma of the endometrium
por: Ebisu, Yusuke, et al.
Publicado: (2020)

Immunohistochemical expression of four different stem cell markers in prostate cancer: High expression of NANOG in conjunction with hypoxia-inducible factor-1α expression is involved in prostate epithelial malignancy
por: MIYAZAWA, KATSUHITO, et al.
Publicado: (2014)

CD133 in Breast Cancer Cells: More than a Stem Cell Marker
por: Brugnoli, Federica, et al.
Publicado: (2019)

Quantitative volumetric imaging of normal, neoplastic and hyperplastic mouse prostate using ultrasound
por: Singh, Shalini, et al.
Publicado: (2015)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

Chromenopyrimidinone Controls Stemness and Malignancy by suppressing CD133 Expression in Hepatocellular Carcinoma
por: Song, Yeonhwa, et al.
Publicado: (2020)

CD133 Act as an Essential Marker in Ovarian Carcinogenesis
por: Ikram, Dzul, et al.
Publicado: (2021)

Prognostic value of immunohistochemical surfactant protein A expression in regenerative/hyperplastic alveolar epithelial cells in idiopathic interstitial pneumonias
por: Nagata, Nobuhiko, et al.
Publicado: (2011)

Immunohistochemical features of a papillary squamous cell carcinoma of the endometrium with transitional cell differentiation
por: Ribeiro-Silva, Alfredo
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_610j2v1a61tjj6l5ftj1t7v601